The email that arrived in the ancient German city of Mainz shortly before 1 am marked a turning point in the global effort to deliver a reliable vaccine against the coronavirus pandemic - and for the little-known biotechnology company...
Full ArticleCovid-19 coronavirus: Vaccine first puts spotlight on German pharma company BioNTech
New Zealand Herald
0 shares
1 views
Advertisement
Related news coverage
Wall Street ends up-and-down day above the flatline as traders mull Trump, the pandemic and bond yields
Proactive Investors
4:15 pm: Traders find their way to positive territory The blue chip index closed 60 points, 0.2%, higher on Tuesday in a sort of..
-
US stocks go positive in mid-afternoon as traders mull Trump, the pandemic and bond yields
Proactive Investors
-
Wall Street loses steam as tech continues to struggle
Proactive Investors
-
COVID-19 dominates 2020 for biotech sector … and everyone else
Proactive Investors
-
China's COVID-19 vaccine is caught in controversy
Mid-Day
You might like
More coverage
China's Fosun Pharma to import 100 million BioNTech vaccine doses
Terra Daily
Beijing (AFP) Dec 16, 2020
A Chinese pharmaceutical company said Wednesday it had agreed to buy at least 100 million..
-
BB BIOTECH AG: Moderna and its COVID-19 vaccine are representative of the innovative power of the entire biotech industry
EQS Group
-
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2
GlobeNewswire
-
Vaccine 1st puts spotlight on German pharma company BioNTech
SeattlePI.com
-
Pfizer 2-dose vaccine 95 per cent effective, no serious side effects
Mid-Day